These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 26495796)
1. Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response. Walsh AJ; Castellanos JA; Nagathihalli NS; Merchant NB; Skala MC Pancreas; 2016 Jul; 45(6):863-9. PubMed ID: 26495796 [TBL] [Abstract][Full Text] [Related]
2. Functional Optical Imaging of Primary Human Tumor Organoids: Development of a Personalized Drug Screen. Walsh AJ; Cook RS; Skala MC J Nucl Med; 2017 Sep; 58(9):1367-1372. PubMed ID: 28588148 [TBL] [Abstract][Full Text] [Related]
3. Cellular Metabolic Heterogeneity In Vivo Is Recapitulated in Tumor Organoids. Sharick JT; Jeffery JJ; Karim MR; Walsh CM; Esbona K; Cook RS; Skala MC Neoplasia; 2019 Jun; 21(6):615-626. PubMed ID: 31078067 [TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response. Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029 [TBL] [Abstract][Full Text] [Related]
5. Metabolic Imaging of Head and Neck Cancer Organoids. Shah AT; Heaster TM; Skala MC PLoS One; 2017; 12(1):e0170415. PubMed ID: 28099487 [TBL] [Abstract][Full Text] [Related]
6. Personalizing pancreatic cancer organoids with hPSCs. Zhang HC; Kuo CJ Nat Med; 2015 Nov; 21(11):1249-51. PubMed ID: 26540385 [No Abstract] [Full Text] [Related]
7. Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment. Sharick JT; Walsh CM; Sprackling CM; Pasch CA; Pham DL; Esbona K; Choudhary A; Garcia-Valera R; Burkard ME; McGregor SM; Matkowskyj KA; Parikh AA; Meszoely IM; Kelley MC; Tsai S; Deming DA; Skala MC Front Oncol; 2020; 10():553. PubMed ID: 32500020 [TBL] [Abstract][Full Text] [Related]
8. Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer. Wang P; Yoo B; Sherman S; Mukherjee P; Ross A; Pantazopoulos P; Petkova V; Farrar C; Medarova Z; Moore A Int J Cancer; 2016 Aug; 139(3):712-8. PubMed ID: 26996122 [TBL] [Abstract][Full Text] [Related]
9. Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer. Walsh AJ; Cook RS; Sanders ME; Aurisicchio L; Ciliberto G; Arteaga CL; Skala MC Cancer Res; 2014 Sep; 74(18):5184-94. PubMed ID: 25100563 [TBL] [Abstract][Full Text] [Related]
10. Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions. Neesse A; Hahnenkamp A; Griesmann H; Buchholz M; Hahn SA; Maghnouj A; Fendrich V; Ring J; Sipos B; Tuveson DA; Bremer C; Gress TM; Michl P Gut; 2013 Jul; 62(7):1034-43. PubMed ID: 22677720 [TBL] [Abstract][Full Text] [Related]
11. The effect of extracellular matrix on the precision medicine utility of pancreatic cancer patient-derived organoids. Lumibao JC; Okhovat SR; Peck KL; Lin X; Lande K; Yomtoubian S; Ng I; Tiriac H; Lowy AM; Zou J; Engle DD JCI Insight; 2024 Jan; 9(1):. PubMed ID: 38051586 [TBL] [Abstract][Full Text] [Related]
12. Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition. Deben C; Boullosa LF; Fortes FR; De La Hoz EC; Le Compte M; Seghers S; Peeters M; Vanlanduit S; Lin A; Dijkstra KK; Van Schil P; Hendriks JMH; Prenen H; Roeyen G; Lardon F; Smits E J Exp Clin Cancer Res; 2024 Mar; 43(1):88. PubMed ID: 38515178 [TBL] [Abstract][Full Text] [Related]
13. Structural and Functional Characterization of Human Stem-Cell-Derived Retinal Organoids by Live Imaging. Browne AW; Arnesano C; Harutyunyan N; Khuu T; Martinez JC; Pollack HA; Koos DS; Lee TC; Fraser SE; Moats RA; Aparicio JG; Cobrinik D Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3311-3318. PubMed ID: 28672397 [TBL] [Abstract][Full Text] [Related]
14. Organoid models of human and mouse ductal pancreatic cancer. Boj SF; Hwang CI; Baker LA; Chio II; Engle DD; Corbo V; Jager M; Ponz-Sarvise M; Tiriac H; Spector MS; Gracanin A; Oni T; Yu KH; van Boxtel R; Huch M; Rivera KD; Wilson JP; Feigin ME; Öhlund D; Handly-Santana A; Ardito-Abraham CM; Ludwig M; Elyada E; Alagesan B; Biffi G; Yordanov GN; Delcuze B; Creighton B; Wright K; Park Y; Morsink FH; Molenaar IQ; Borel Rinkes IH; Cuppen E; Hao Y; Jin Y; Nijman IJ; Iacobuzio-Donahue C; Leach SD; Pappin DJ; Hammell M; Klimstra DS; Basturk O; Hruban RH; Offerhaus GJ; Vries RG; Clevers H; Tuveson DA Cell; 2015 Jan; 160(1-2):324-38. PubMed ID: 25557080 [TBL] [Abstract][Full Text] [Related]
15. Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer. Tao Z; Muzumdar MD; Detappe A; Huang X; Xu ES; Yu Y; Mouhieddine TH; Song H; Jacks T; Ghoroghchian PP Nano Lett; 2018 Apr; 18(4):2195-2208. PubMed ID: 29533667 [TBL] [Abstract][Full Text] [Related]
16. Development of organoid-based drug metabolism model. Park E; Kim HK; Jee J; Hahn S; Jeong S; Yoo J Toxicol Appl Pharmacol; 2019 Dec; 385():114790. PubMed ID: 31678242 [TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts in pancreatic adenocarcinoma. Pan B; Liao Q; Niu Z; Zhou L; Zhao Y Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509 [TBL] [Abstract][Full Text] [Related]
18. Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis. Díaz Osterman CJ; Gonda A; Stiff T; Sigaran U; Valenzuela MM; Ferguson Bennit HR; Moyron RB; Khan S; Wall NR Pancreas; 2016 Jan; 45(1):101-9. PubMed ID: 26348467 [TBL] [Abstract][Full Text] [Related]
19. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer. Xie BY; Wu AW Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340 [TBL] [Abstract][Full Text] [Related]
20. K-Ras-driven pancreatic cancer mouse model for anticancer inhibitor analyses. Cook N; Olive KP; Frese K; Tuveson DA Methods Enzymol; 2008; 439():73-85. PubMed ID: 18374157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]